Clinical Outcomes After Laser Hemorrhoidoplasty
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSanliurfa Education and Research Hospital
About this trial
This single-center prospective observational study aims to evaluate clinical outcomes, postoperative pain scores, complications, and patient satisfaction in adults undergoing laser hemorrhoidoplasty for symptomatic internal hemorrhoidal disease. Additional objectives are to assess the relationship between hemorrhoid stage, dominant presenting symptoms, operative technical details, and postoperative outcomes. No study-specific intervention beyond routine clinical care and follow-up will be performed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 years or older
Symptomatic internal hemorrhoidal disease
Scheduled to undergo laser hemorrhoidoplasty
Willingness to participate and provision of informed consent
Disqualifiers
Grade IV hemorrhoidal disease
Acute thrombosed hemorrhoids
Additional anorectal pathology such as anal fissure, fistula, or perianal abscess
History of inflammatory bowel disease or colorectal malignancy
Trial population
Adult patients with symptomatic internal hemorrhoidal disease who are scheduled to undergo laser hemorrhoidoplasty at the General Surgery Clinic of Sanliurfa Education and Research Hospital.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Laser Hemorrhoidoplasty
Procedure/SurgeryLaser-based minimally invasive treatment of internal hemorrhoidal disease performed as part of routine clinical care.
Treatment groups
60 Participants
are divided into 1 treatment groupGroup A: Patients undergoing laser hemorrhoidoplasty1 intervention
Trial outcomes
Primary outcomes
1
Postoperative pain score
Postoperative pain assessed using a 0 to 10 Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain; higher scores indicate worse pain.
Time frame
At 6 hours, 24 hours, and 1 week after surgerySecondary outcomes
1
Duration of postoperative analgesic use
Duration of postoperative analgesic use, measured in days.
Time frame
From the day of surgery through 30 days after surgery2
Length of hospital stay
Postoperative hospital stay, measured in days from the date of surgery to the date of discharge.
Time frame
From the day of surgery to hospital discharge, up to 7 days3
Incidence of predefined early postoperative complications
Number and proportion of patients who develop any predefined early postoperative complication within 30 days after laser hemorrhoidoplasty. Predefined complications include postoperative bleeding, urinary retention, anal thrombosis, infection, severe pain, and anal stenosis. Patients without any of these events will be classified as having no complication.
Time frame
Within 30 days after surgery4
Time to return to daily activities
Time required to return to usual daily activities, measured in days.
Time frame
Up to 30 days after surgerySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov